Original articleThe BRCA2 sequence variant IVS19+1G→A leads to an aberrant transcript lacking exon 19
Section snippets
Acknowledgements
This study was supported by grants from the Ministero della Ricerca Scientifica e Tecnologica (COFIN'01), AIRC (Coordinated Project: “Italian Consortium for Hereditary Breast and Ovarian Cancer”), and “Fondazione Cassa di Risparmio di Padova e Rovigo”.
References (13)
- et al.
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
The Breast Cancer Linkage Consortium. Am J Hum Genet
(1998) - et al.
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
Nat Genet
(1996) - et al.
Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families
Hum Mol Genet
(2001) - et al.
A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes
Nat Genet
(2001) - et al.
A BRCA1 variant, IVS23+1G→A, causes abnormal RNA splicing by deleting exon 23
Cancer Genet Cytogenet
(2001) - et al.
Mutation in the coding region of the BRCA1 gene leads to aberrant splicing of the transcript
Hum Mutat
(1999)
There are more references available in the full text version of this article.
Cited by (5)
Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples
2016, Journal of Medical GeneticsAssessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes
2012, Breast Cancer Research and TreatmentAlterations of pre-mRNA splicing in cancer
2005, Genes Chromosomes and Cancer
- 1
The authors contributed equally to this work.
Copyright © 2003 Elsevier Science Inc. All rights reserved.